Pegfilgrastim: all 137 studies that test it
Page 2 of 2. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast CancerActive, not recruitingNCT00433420Phase 3
- Pegfilgrastim Versus Filgrastim After High-dose ChemotherapyCompletedNCT00410696Phase 2
- Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic PatientsCompletedNCT00364468Phase 2
- Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma CancerCompletedNCT00352300Phase 1
- Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphomaCompletedNCT00306111Phase 2
- Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By SurgeryStatus unknownNCT00301925Phase 3
- Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLCTerminatedNCT00291850Phase 2
- Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and IfosfamideCompletedNCT00283621Not applicable
- Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With PegfilgrastimCompletedNCT00280787Phase 2
- A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With CancerCompletedNCT00277160Phase 4
- ACCELERATE: Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Pegfilgrastim and Darbepoetin Alfa Support for the Treatment of Women With Breast CancerCompletedNCT00261313Phase 2
- Study of R-ACVBP Regimen Supported by Pegfilgrastim in High-Risk Diffuse Large B-Cell LymphomaCompletedNCT00169143Phase 2
- Pegfilgrastim and Darbepoetin Alfa in Support of Adjuvant Chemotherapy for Breast CancerCompletedNCT00146562Phase 2
- A Study of Cyclophosphamide/Methotrexate/5-Fluorouracil (CMF) With Pegfilgrastim in Subjects With Breast CancerCompletedNCT00124111Phase 2
- Treatment for Elderly Patients With High Risk Breast CancerCompletedNCT00117910Phase 3
- Treatment for Subjects With Non-Hodgkin's LymphomaCompletedNCT00117897Phase 2
- A Study of Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim in Subjects With Non-Hodgkin's LymphomaCompletedNCT00117455Phase 2
- A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole BloodCompletedNCT00117442Phase 2
- Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)CompletedNCT00115414Phase 2
- Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During ChemotherapyCompletedNCT00115206Phase 4
- Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's LymphomaCompletedNCT00115193Phase 2
- Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)CompletedNCT00114764Phase 2
- Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast CancerCompletedNCT00107510Phase 2
- Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine LeiomyosarcomaCompletedNCT00101127Phase 2
- Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple MyelomaCompletedNCT00067639Phase 2
- Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast CancerCompletedNCT00066443Phase 1/2
- Pegfilgrastim PBPC Mobilization StudyCompletedNCT00066092Phase 2
- Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue SarcomaCompletedNCT00061984Phase 3
- Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung CarcinomaCompletedNCT00050674Phase 2
- Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD ChemotherapyCompletedNCT00038558Phase 3
- A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's LymphomaCompletedNCT00038545Phase 2
- Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving ChemotherapyCompletedNCT00035620Phase 2
- Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving ChemotherapyCompletedNCT00035594Phase 3
- Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the UterusCompletedNCT00031629Phase 2
- Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast CancerStatus unknownNCT00030758Phase 4
- Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive ChemotherapyCompletedNCT00004853Phase 1
- Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's LymphomaCompletedNCT00004192Phase 2